Skip to content

Contact +44 (0) 20 7060 7474 email us

Diagnostics

DNA Probes-Based Diagnostics

A Worldwide Market Review

Publication Date November 2009
Publisher BizAcumen
Product Type Report
Pages 249
ISBN Number not applicable
Product Code BIZ00016

Price

£1,980.00
approximately: $2,998 | €2,210

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

DNA probes-based diagnostics is an emerging application area in the in-vitro diagnostics industry. DNA probes, popular across the medical diagnostics industry, determine the presence of a suspected disease caused by an organism or pathogen. Based on the amount of target DNA present, probes can be used either directly to detect target DNA, or indirectly target DNA through amplification that creates a number of copies of specific nucleotide. Increased automation of diagnostic tests, discovery of new diagnostic markets, rising investments in pharmaceutical and pharmacogenomics research, and advancements in DNA array technologies are major growth facilitators for the DNA probes-based diagnostic products market.

In the area of molecular in-vitro diagnostics, DNA based diagnostics represent the most attractive, and fast growing clinical diagnostics technology primarily due to high levels of reliability, sensitivity, and rapidity. Numerous technology breakthroughs in the area of DNA diagnostics include PCR-based techniques, DNA microarrays and microfluidics, fluorescent in situ hybridization (FISH), SNP detection, and DNA nanotechnology, among several others. Breaking from the realm of research, current applications of DNA diagnostics are becoming widespread, with millions of samples from blood, hair and tissues, being analyzed for the positive identification of pathogens and diseases.

These and other market data and trends are presented in "DNA Probes-based Diagnostics: A Worldwide Market Review" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Contents

  • 1.Methodology
    • Study Reliability and Reporting Limitations
    • Disclaimers
    • Quantitative Techniques & Reporting Level
  • 2.Global Market Overview and Outlook
    • DNA Probes: Robust Growth Ahead
    • Growth Drivers
    • Growth Inhibitors
    • Genetic Profiling of Pathogens: A Road Less Traveled
    • Roche's Entry into The Hall of Molecular Fame
    • DNA Technology: An Evolutionary Scan
    • Opportunities
  • 3.Market Trends/Issues
    • DNA Tests: Finding Use in Numerous Applications
    • World's Aging Population Drives The Popularity of DNA-Probe Tests
    • Reimbursements: ""under The Umbrella""
    • Evolution of New & Virulent Infectious Agents
    • The Enlightened Consumer of The 21st Century
    • Challenges in Widespread Deployment of DNA Based Diagnostics
    • Miniaturization: An Uphill Task
    • Improvements in Assay Capabilities
    • Information Handling & Processing: The Soft Side of Diagnostics
    • Integration: The Ultimate Challenge
    • United States: Unraveling The Country's Edge in DNA Based Diagnostics
  • 4.Product Facts
    • Infectious Diseases
    • Cancer
    • Genetic Predisposition
    • Identity/Forensics
    • Molecular Hla Testing
    • Other Diagnostic Applications
  • 5.Molecular Diagnostics - A Primer
    • Implications for Clinical Diagnostics
    • Implications for Clinical Diagnostics
    • Need of The Hour
    • Molecular Diagnostics: Marking The Convergence of Numerous Technologies
    • Impact of The Human Genome Project
    • Molecular Diagnostics: Domain of The Developed Countries
    • ""tailored Patient Management"": An Epitomized Future of Molecular Diagnostics
    • Futuristics: A Rumination
  • 6.Corporate Developments
    • Genzyme Enters into Licensing Agreement with Moffitt Cancer Center
    • Roche Diagnostics Receives Approval for Elecsys Anti-Hcv Assay
    • Biomrieux and Find Ink Memorandum of Understanding
    • Bd Establishes Second Production Facility in China
    • Beckman Coulter Bags Rights to Hepatitis C Virus Test from Siemens
    • Affymetrix Enters into Partnership with Pathwork Diagnostics
    • Luminex Signs Distribution and Sales Agreement with Abbott
    • Gen-Probe to Acquire Innogenetics
    • Biocept to Introduce I.D.Rh(D)
    • Luminex Molecular Introduces New XtagRespiratory Viral Panel
    • Gen-Probe Introduces Aptima Hpv Assay in Europe
    • Genzyme Genetics Introduces Prenatal Diagnosis and Carrier Testing
    • Affymetrix Launches New Cytogenetic Solution
    • Siemens Acquires Dade Behring
    • Sorenson Genomics Acquires Identigene
    • Bioserve Takes over Genomics Collaborative
    • Qiagen to Merge with Egene
  • 3m Enters into Collaboration with Gen-Probe
    • Luminex Corporation Completes Acquisition of Tm Bioscience
    • Ipsen and Biomrieux Enter into Theragnostics Agreement
    • Celera Acquires Atria Genetics
    • Celera Acquires Berkeley Heartlab
    • Beckman Coulter Enters into Partnership
    • Affymetrix Partners with Ipsogen for in-Vitro Diagnostic Cancer Testing
    • Siemens Medical Solutions Acquires Bayer's Diagnostic Division
    • Genetic Solutions and Catapult Merge to Establish Catapult Genetics
    • Gen-Probe and Millipore Ink Agreement to Market Mtc-Ni Test
    • Qiagen Acquires Digene Corporation
    • Biomrieux Unveils Vidas C
    • Biomrieux Unveils Nuclisens Easyq Hpv
    • Biomrieux Introduces Vidas Nt-Probnp
    • Abbott Molecular Rolls out Six DNA Probes
  • 7.Major Players
    • Abbott Laboratories (US)
    • Affymetrix, Inc. (US)
    • Becton, Dickinson & Company (US)
    • Beckman Coulter, Inc. (US)
    • Biomrieux (France)
    • Celera Group (US)
    • Gen-Probe Incorporated (US)
    • Genzyme Corporation (US)
    • Luminex Molecular Diagnostics (Canada)
    • Qiagen (US)
    • Roche Diagnostics (Switzerland)
    • Siemens Healthcare Diagnostics, Inc. (US)
  • 8.Market Analytics
  • 9.The United States
  • 10.Canada
  • 11.Japan
  • 12.Europe
    • A.France
    • B.Germany
    • C.Italy
    • D.The United Kingdom
    • E.Rest of Europe
  • 13.Asia Pacific
  • 14.Latin America
  • Exhibits
    • Table 1: Global DNA Probes-Based Diagnostic Market by Region for The Period 2007-2015 (Sales in US$ Million)
    • Table 2: Percentage Breakdown of Global DNA Probes-Based Diagnostic Market by Region for The Years 2008 &
    • Table 3: Global DNA Probes-Based Diagnostics (Infectious Disease Diagnosis) Market by Region for The Period 2007-2015 (Sales in US$ Million)
    • Table 4: Percentage Breakdown of Global DNA Probes-Based Diagnostics (Infectious Disease Diagnosis) Market by Region for The Years 2008 &
    • Table 5: Global DNA Probes-Based Diagnostics (Cancer Diagnosis) Market by Region for The Period 2007-2015 (Sales in US$ Million)
    • Table 6: Percentage Breakdown of Global DNA Probes-Based Diagnostics (Cancer Diagnosis) Market by Region for The Years 2008 &
    • Table 7: Global DNA Probes-Based Diagnostics (Genetic Predisposition Diagnosis) Market by Region for The Period 2007-2015 (Sales in US$ Million)
    • Table 8: Percentage Breakdown of Global DNA Probes-Based Diagnostics (Genetic Predisposition Diagnosis) Market by Region for The Years 2008 &
    • Table 9: Global DNA Probes-Based Diagnostics (Identity/Forensics Diagnosis) Market by Region for The Period 2007-2015 (Sales in US$ Million)
    • Table 10: Percentage Breakdown of Global Identity/Forensics Market by Region for The Years 2008 &
    • Table 11: Global DNA Probes-Based Diagnostics (Molecular Hla Testing) Market by Region for The Period 2007-2015 (Sales in US$ Million)
    • Table 12: Percentage Breakdown of DNA Probes-Based Diagnostics (Molecular Hla Testing) Market by Region for The Years 2008 &
    • Table 13: Global Market for DNA Probes-Based Diagnostics in Other Types of Diagnosis by Region for The Period 2007-2015 (Sales in US$ Million)
    • Table 14: Percentage Breakdown of Global Market for DNA Probes-Based Diagnostics in Other Types of Diagnosis by Region for The Years 2008 &
    • Table 15: DNA Probes-Based Diagnostic Market by Application in The US: 2007- 2015 (Sales in US$ Million)
    • Table 16: Percentage Breakdown of DNA Probes-Based Diagnostic Market by Application in The US for The Years 2008 &
    • Table 17: DNA Probes-Based Diagnostic Market by Application in Canada: 2007-2015 (Sales in US$ Million)
    • Table 18: Percentage Breakdown of DNA Probes-Based Diagnostic Market by Application in Canada for The Years 2008 &
    • Table 19: DNA Probes-Based Diagnostic Market by Application in Japan: 2007- 2015 (Sales in US$ Million)
    • Table 20: Percentage Breakdown of DNA Probes-Based Diagnostic Market by Application in Japan for The Years 2008 &
    • Table 21: DNA Probes-Based Diagnostic Market by Region in Europe: 2007- 2015 (Sales in US$ Million)
    • Table 22: Percentage Breakdown of DNA Probes-Based Diagnostic Market by Region in Europe for The Years 2008 &
    • Table 23: DNA Probes-Based Diagnostic Market by Application in Europe: 2007-2015 (Sales in US$ Million)
    • Table 24: Percentage Breakdown of DNA Probes-Based Diagnostic Market by Application in Europe for The Years 2008 &
    • Table 25: DNA Probes-Based Diagnostic Market by Application in France: 2007- 2015 (Sales in US$ Million)
    • Table 26: Percentage Breakdown of DNA Probes-Based Diagnostic Market by Application in France for The Years 2008 &
    • Table 27: DNA Probes-Based Diagnostic Market by Application in Germany: 2007-2015 (Sales in US$ Million)
    • Table 28: Percentage Breakdown of DNA Probes-Based Diagnostic Market by Application in Germany for The Years 2008 &
    • Table 29: DNA Probes-Based Diagnostic Market by Application in Italy: 2007-2015 (Sales in US$ Million)
    • Table 30: Percentage Breakdown of DNA Probes-Based Dmiagnostic Market by Application in Italy for The Years 2008 &
    • Table 31: DNA Probes-Based Diagnostic Market by Application in The UK: 2007- 2015 (Sales in US$ Million)
    • Table 32: Percentage Breakdown of DNA Probes-Based Diagnostic Market by Application in The UK for The Years 2008 &
    • Table 33: DNA Probes-Based Diagnostic Market by Application in Rest of Europe: 2007-2015 (Sales in US$ Million)
    • Table 34: Percentage Breakdown of DNA Probes-Based Diagnostic Market by Application in Rest of Europe for The Years 2008 &
    • Table 35: DNA Probes-Based Diagnostic Market by Application in Asia Pacific: 2007-2015 (Sales in US$ Million)
    • Table 36: Percentage Breakdown of DNA Probes-Based Diagnostic Market by Application in Asia Pacific for The Years 2008 &
    • Table 37: DNA Probes-Based Diagnostic Market by Application in Latin America: 2007-2015 (Sales in US$ Million)
    • Table 38: Percentage Breakdown of DNA Probes-Based Diagnostic Market by Application in Latin America for The Years 2008 &
  • Companies Profiled